1. Role of interleukin‐35 in cardiovascular diseases
   Jialun Zhang et al, 2023, Scandinavian Journal of Immunology CrossRef
2. Evolving targets for the treatment of atherosclerosis
   Ankita Solanki et al, 2018, Pharmacology & Therapeutics CrossRef
3. IL-35 promoted STAT3 phosphorylation and IL-10 production in B cells, but its production was reduced in patients with coronary artery diseases
   Zhendong Zhu et al, 2018, Human Immunology CrossRef
4. Association between interleukin-35 polymorphisms and coronary heart disease in the Chinese Zhuang population
   Yingzhong Lin et al, 2018, Coronary Artery Disease CrossRef
5. HMGB1 suppress the expression of IL-35 by regulating Naïve CD4+ T cell differentiation and aggravating Caspase-11-dependent pyroptosis in acute lung injury
   Ke Xie et al, 2021, International Immunopharmacology CrossRef
6. Decreased regulatory T‑cell frequency and interleukin‑35 levels in patients with rheumatoid arthritis
   Xia Zhang et al, 2018, Experimental and Therapeutic Medicine CrossRef
7. Fimasartan reduces neointimal formation and inflammation after carotid arterial injury in apolipoprotein E knockout mice
   Jong-Ho Kim et al, 2019, Molecular Medicine CrossRef
8. Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges
   Jing Ye et al, 2020, Frontiers in Pharmacology CrossRef
9. IL-35 interferes with splenic T cells in a clinical and experimental model of acute respiratory distress syndrome
   Chuan-jiang Wang et al, 2019, International Immunopharmacology CrossRef
10. IL-35, as a newly proposed homeostasis-associated molecular pattern, plays three major functions including anti-inflammatory initiator, effector, and blocker in cardiovascular diseases
    Xinyuan Li et al, 2019, Cytokine CrossRef
11. Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis
    Qiong Wang et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
12. Interleukin-35 ameliorates cardiovascular disease by suppressing inflammatory responses and regulating immune homeostasis
    Jie Feng et al, 2022, International Immunopharmacology CrossRef
13. Interleukin-35: Structure, Function and Its Impact on Immune-Related Diseases
    Cheng Ye et al, 2021, Journal of Interferon & Cytokine Research CrossRef
14. Interleukin-12p35 Deficiency Reverses the Th1/Th2 Imbalance, Aggravates the Th17/Treg Imbalance, and Ameliorates Atherosclerosis in ApoE-/- Mice
    Ying Huang et al, 2019, Mediators of Inflammation CrossRef
15. Interleukin-35 Mitigates ox-LDL-Induced Proatherogenic Effects via Modulating miRNAs Associated with Coronary Artery Disease (CAD)
    Shipra Bhansali et al, 2023, Cardiovascular Drugs and Therapy CrossRef
16. Interleukin 17, the double-edged sword in atherosclerosis
    Aysan Moeinafshar et al, 2022, Immunobiology CrossRef
17. IL-35 (Interleukin-35) Suppresses Endothelial Cell Activation by Inhibiting Mitochondrial Reactive Oxygen Species-Mediated Site-Specific Acetylation of H3K14 (Histone 3 Lysine 14)
    Xinyuan Li et al, 2018, Arteriosclerosis, Thrombosis, and Vascular Biology CrossRef
18. Immunobiology of Atherosclerosis: A Complex Net of Interactions
    null Herrero-Fernandez et al, 2019, International Journal of Molecular Sciences CrossRef